探討EGFR基因表現與合併藥物對攝護腺癌治療的影響(1/3)

Pharmacology, Toxicology and Pharmaceutical Science

1. Prostate Cancer 100%
2. Cancer Growth 100%
3. Combination Therapy 100%
4. Epidermal Growth Factor Receptor 100%
5. microRNA 1 93%
6. Malignant Neoplasm 12%
7. Metastasis 12%
8. Metastasis Potential 12%
9. Drug Resistance 12%
10. Bone Metastasis 6%
11. Tumor Resistance 6%
12. Breast Cancer 6%
13. Cell Viability 6%
14. Pharmacotherapy 6%
15. Lung Cancer 6%
16. Chemotherapy 6%
17. Tumor Growth 6%
18. Neoplasm 6%
19. Carcinogenesis 6%
20. Tumor Suppressor Protein 6%